3/04/2013

There is now a new quit smoking drug available in the market. This latest breakthrough is known as Varenicline. It is able to help smokers snub out their addiction by working on the brain.



More specifically, it is working on the pleasure centres of the brain. It prevents nicotine from attaching to the brain. By blocking nicotine, the brain is not stimulated. This reduces the body dependence on nicotine.



Instead of having nicotine attaching to the receptors to the brain, Varenicline is attached. This helps to release the dopamine hormone which makes you feel good without smoking.



Without nicotine stimulating the brain, the number of nicotine receptors is reduced and the urge to smoke reduces.



Drugs used for smoking cessation treatments used to be merely substitutes that helped get an addict off the habit or made him feel sick if he insists on smoking. However, nowadays, doctors have become interested in managing the chemical reactions that happen in the body.



Another quit smoking drug available to the masses is Bupropion. This was originally developed o treat depression. Later, it was found to reduce the desire of smokers to smoke.



Currently, it is believed that this drug helps to stop the decrease the dopamine levels when smoking stops. By reducing the withdrawal symptoms that comes with lower dopamine levels, smokers will find it easier to stop smoking.



These new quit smoking drugs do not absolve the responsibility of smokers. In fact, smokers will need to develop skills to resist drug use and replace such drug-using activities with other productive activities that will keep their minds away from their favourite kick.
Posted by Admin On 7:02 AM No comments

0 comments:

Post a Comment

  • RSS
  • Delicious
  • Digg
  • Facebook
  • Twitter
  • Linkedin
  • Youtube

Blog Archive